Cue biopharma to host business update call and webcast

Boston, april 14, 2025 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific t cells for the treatment of cancer and autoimmune disease, today announced that it will host a conference call and webcast to provide a business update on tuesday, april 15, 2025 at 4:30 p.m. et.
CUE Ratings Summary
CUE Quant Ranking